The AcCREDiT 2 Study

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Chronic Respiratory ConditionsCOPDPneumoniaBacterial InfectionsViral InfectionsRespiratory Exacerbation
Trial Locations (1)

M23 9LT

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT07029672 - The AcCREDiT 2 Study | Biotech Hunter | Biotech Hunter